McEnany Patrick J's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Nov 13, 2024
- Accession no.
- 0001161697-24-000445
- Filed
- Nov 13, 2024
- Trade date
- Nov 11-12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $11.5M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McEnany Patrick JCIK 0000929985 | Director, Other: Chairman of Board of Directors |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +230,000 | $4.01 | +$922,300 | 4,708,169 | Direct | |
| Nov 11, 2024 | Common stock, par value $0.001 per share | SSaleDisposed | −230,000 | $23.55 | −$5,416,500 | 4,478,169 | Direct | |
| Nov 12, 2024 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +70,000 | $4.01 | +$280,700 | 4,548,169 | Direct | |
| Nov 12, 2024 | Common stock, par value $0.001 per share | SSaleDisposed | −70,000 | $23.42 | −$1,639,400 | 4,478,169 | Direct | |
| Nov 12, 2024 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +192,000 | $3.54 | +$679,680 | 4,670,169 | Direct | |
| Nov 12, 2024 | Common stock, par value $0.001 per share | SSaleDisposed | −192,000 | $23.20 | −$4,454,400 | 4,478,169 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | Common Stock | MOption exerciseDisposed | −230,000 | $0.00 | $0 | 2,362,745 | Direct | |
| Nov 12, 2024 | Common Stock | MOption exerciseDisposed | −70,000 | $0.00 | $0 | 2,292,745 | Direct | |
| Nov 12, 2024 | Common Stock | MOption exerciseDisposed | −192,000 | $0.00 | $0 | 2,100,745 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.